Search alternatives:
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
progress decrease » progressive decrease (Expand Search), problems decreased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
101
-
102
<sup>1</sup>H NMR spectra for kylo-0603.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
103
<sup>13</sup>C NMR spectra for Kylo-0603.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
104
-
105
-
106
-
107
Effects of Kylo-0603 on the expression of related genes of the MASH mouse models.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
108
General procedure for the synthesis of B.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
109
Effects of Kylo-0603 on body weight, organ weight, and body fat content.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
110
The body weight and cholesterol levels of the mice were recorded before the administration of the drug.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
111
The trends of cholesterol metabolism-related gene expression in liver tissue.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
112
-
113
-
114
The Fibrosis scoring by Sirius Red staining and SHG/TPEF.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
115
Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3).
Published 2025Subjects: “…attenuates fibrosis progression…”
-
116
After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
117
-
118
The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention.
Published 2025Subjects: “…attenuates fibrosis progression…”
-
119
Hematoxylin and eosin (H&E) staining, Sirius Red staining, and Oil Red staining of liver tissues from mice in each group after 8 weeks of treatment with either vehicle or Kylo-0603...
Published 2025Subjects: “…attenuates fibrosis progression…”
-
120
Effect of Kylo-0603 drug on the reversal of steatosis and inhibition of fibrotic process in liver tissues of the MASH mouse models (F2 ~ 3), analyzed by SHG/TPEF microscopy combine...
Published 2025Subjects: “…attenuates fibrosis progression…”